Efficacy and safety of <scp>SGLT2</scp> inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report

Takashi Yagi, Daisuke Aotani, Chie Hasegawa, Yuki Shimizu, Hiroyuki Koyama, Yoshiro Maezawa, Koutaro Yokote, Tomohiro Tanaka

Open source

DOI
10.1111/jdi.70203
Published
2025-11-28
Container
Journal of Diabetes Investigation
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jdi.70203,
  title = {Efficacy and safety of
                    <scp>SGLT2</scp>
                    inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report},
  author = {Takashi Yagi and Daisuke Aotani and Chie Hasegawa and Yuki Shimizu and Hiroyuki Koyama and Yoshiro Maezawa and Koutaro Yokote and Tomohiro Tanaka},
  year = {2025},
  journal = {Journal of Diabetes Investigation},
  doi = {10.1111/jdi.70203},
  url = {https://doi.org/10.1111/jdi.70203}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of
                    <scp>SGLT2</scp>
                    inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
AU  - Takashi Yagi
AU  - Daisuke Aotani
AU  - Chie Hasegawa
AU  - Yuki Shimizu
AU  - Hiroyuki Koyama
AU  - Yoshiro Maezawa
AU  - Koutaro Yokote
AU  - Tomohiro Tanaka
PY  - 2025
JO  - Journal of Diabetes Investigation
DO  - 10.1111/jdi.70203
UR  - https://doi.org/10.1111/jdi.70203
ER  - 

APA

Yagi, T., Aotani, D., Hasegawa, C., Shimizu, Y., Koyama, H., Maezawa, Y., Yokote, K., & Tanaka, T. (2025). Efficacy and safety of <scp>SGLT2</scp> inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70203

Source records